Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
3701
Tectonic Therapeutic
TECX
$682M
| $230K | ﹤0.01% |
1,476
-257
| -15% | -$51.8K |
|
|
CBAY
3702
DELISTED
Cymabay Therapeutics
CBAY
| $230K | ﹤0.01% |
31,739
-87,062
| -73% | -$466K |
|
|
ATRS
3703
DELISTED
Antares Pharma, Inc.
ATRS
| $230K | ﹤0.01% |
85,220
-14,994
| -15% | -$41.5K |
|
3704
Geron
GERN
$943M
| $229K | ﹤0.01% |
131,556
-9,235
| -7% | -$17.1K |
|
3705
Mitek Systems
MITK
$877M
| $229K | ﹤0.01% |
17,991
-3,674
| -17% | -$41.4K |
|
3706
Stoke Therapeutics
STOK
$2.02B
| $229K | ﹤0.01% |
6,815
-3,166
| -32% | -$90.4K |
|
|
UMH
3707
UMH Properties
UMH
$1.4B
| $229K | ﹤0.01% |
16,830
-3,345
| -17% | -$44.6K |
|
|
RETA
3708
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $229K | ﹤0.01% |
2,343
-17,586
| -88% | -$2.2M |
|
|
SABA
3709
Saba Capital Income & Opportunities Fund II
SABA
$220M
| $228K | ﹤0.01% |
18,506
+1,672
| +10% | +$18.1K |
|
3710
Tootsie Roll Industries
TR
$3.08B
| $228K | ﹤0.01% |
8,804
-2,113
| -19% | -$56.4K |
|
|
TGP
3711
DELISTED
Teekay LNG Partners L.P.
TGP
| $228K | ﹤0.01% |
21,696
+1,454
| +7% | +$16.3K |
|
3712
Ennis
EBF
$559M
| $227K | ﹤0.01% |
13,038
-2,367
| -15% | -$41.5K |
|
3713
CALL
Harley-Davidson
HOG
$2.89B
| $226K | ﹤0.01% |
9,200
-2,000
| -18% | -$53.9K |
|
3714
Surgery Partners
SGRY
$1.97B
| $226K | ﹤0.01% |
10,311
-2,181
| -17% | -$38.8K |
|
|
MMP
3715
PUT
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $226K | ﹤0.01% |
6,600
| – | – |
|
3716
PUT
Aflac
AFL
$60.9B
| $225K | ﹤0.01% |
6,200
| – | – |
|
3717
Ollie's Bargain Outlet
OLLI
$4.62B
| $225K | ﹤0.01% |
2,574
-31,784
| -93% | -$3.11M |
|
|
SOHU
3718
Sohu.com
SOHU
$378M
| $225K | ﹤0.01% |
11,365
-1,484
| -12% | -$25.7K |
|
3719
CALL
Molson Coors Class B
TAP
$7.97B
| $225K | ﹤0.01% |
6,700
-295,000
| -98% | -$10.6M |
|
3720
UNIFI
UFI
$120M
| $225K | ﹤0.01% |
17,574
+4,558
| +35% | +$56.9K |
|
|
BEST
3721
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $225K | ﹤0.01% |
3,750
+1,640
| +78% | +$134K |
|
3722
Brookdale Senior Living
BKD
$3.02B
| $224K | ﹤0.01% |
87,812
-19,921
| -18% | -$54.9K |
|
|
QADA
3723
DELISTED
QAD Inc.
QADA
| $224K | ﹤0.01% |
5,310
-1,055
| -17% | -$44.3K |
|
3724
Crinetics Pharmaceuticals
CRNX
$8.99B
| $223K | ﹤0.01% |
14,241
-2,547
| -15% | -$38.9K |
|
3725
Old Republic International
ORI
$10.3B
| $222K | ﹤0.01% |
15,039
-60,208
| -80% | -$962K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.